Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Am J Med Sci ; 352(3): 302-5, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27650236

ABSTRACT

Ossifying fibromas of the maxillofacial bones are an uncommon form of benign neoplasm usually treated by surgical excision. Up to 30% of patients with hyperparathyroidism-jaw tumor syndrome, a rare form of multiple endocrine neoplasia resulting from autosomal dominant inactivating mutation of the Hrpt2 tumor suppressor gene, initially present with ossifying fibromas. Coincident hypercalcemia because of the presence of parathyroid adenoma is common in these patients, of whom 15% may have or may develop parathyroid carcinoma. The authors present a case of severe postsurgical hypercalcemia after removal of a large maxillary ossifying fibroma in a patient with previously unrecognized hyperparathyroidism-jaw tumor AU3 syndrome.


Subject(s)
Adenoma/pathology , Calcium/blood , Fibroma/pathology , Hypercalcemia/pathology , Hyperparathyroidism/pathology , Jaw Neoplasms/pathology , Adenoma/blood , Adenoma/surgery , Adult , Calcimimetic Agents/administration & dosage , Calcimimetic Agents/therapeutic use , Calcitonin/administration & dosage , Calcitonin/therapeutic use , Calcium/urine , Cinacalcet/administration & dosage , Cinacalcet/therapeutic use , Diagnosis, Differential , Female , Fibroma/blood , Fibroma/surgery , Humans , Hypercalcemia/blood , Hypercalcemia/surgery , Hyperparathyroidism/blood , Hyperparathyroidism/surgery , Jaw Neoplasms/blood , Jaw Neoplasms/surgery , Parathyroid Hormone/antagonists & inhibitors , Parathyroid Hormone/metabolism , Parathyroidectomy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL